La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Lincoln Pharmaceuticals Bilan de santé
Santé financière contrôle des critères 6/6
Lincoln Pharmaceuticals possède un total de capitaux propres de ₹5.9B et une dette totale de ₹10.7M, ce qui porte son ratio d'endettement à 0.2%. Son actif total et son passif total sont ₹7.0B et de ₹1.1B. L'EBIT de Lincoln Pharmaceuticals est ₹906.2M ce qui fait que son ratio de couverture des intérêts 60.9. Elle dispose de liquidités et de placements à court terme de ₹1.5B.
Informations clés
0.2%
Ratio d'endettement
₹10.67m
Dette
| Ratio de couverture des intérêts | 60.9x |
| Argent liquide | ₹1.53b |
| Fonds propres | ₹5.93b |
| Total du passif | ₹1.07b |
| Total des actifs | ₹7.00b |
Mises à jour récentes de la santé financière
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Recent updates
Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?
Sep 06Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Analyse de la situation financière
Passif à court terme: Les actifs à court terme de LINCOLN ( ₹4.5B ) dépassent ses passifs à court terme ( ₹922.8M ).
Passif à long terme: Les actifs à court terme de LINCOLN ( ₹4.5B ) dépassent ses passifs à long terme ( ₹151.8M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: LINCOLN dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de LINCOLN a été réduit de 11.8% à 0.2% au cours des 5 dernières années.
Couverture de la dette: La dette de LINCOLN est bien couverte par le flux de trésorerie opérationnel ( 5925.9% ).
Couverture des intérêts: Les paiements d'intérêts de LINCOLN sur sa dette sont bien couverts par l'EBIT ( 60.9 x couverture).